Clifford Chance advises Actis on the acquisition of a significant stake in Medis Group
Leading international law firm Clifford Chance has advised Actis, leading growth market investor, on significant stake investment in Medis Group.
Medis is a prominent branded generic pharmaceuticals business in Tunisia and Algeria. Actis acquired a meaningful stake in the business from Africinvest, one of the key Pan African Mid Cap PE players, and from the founding Boujbel family.